ATRC-101 - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://jitc.bmj.com//content/9/Suppl_2/A548
 
John Powderly 1; Jeremy Jones 2; Tanios Bekaii-Saab 2; Yan Xing 3; S John Weroha 2; Susanna Ulahannan 4; Deborah Doroshow 5; Frances Valdes-Albini 6; Carl Millward 7; Kimberly Walter 7; Andrew Wrong 7; Paul Del Castillo 7; Lixia Wang 7; Ngan Nguyen 7; Mark Whidden 7; Jonathan Benjamin 7; Steven Isakoff 8
 
Oct 1, 2021
 
Prev Next